Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
Saved in:
| Title: | Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients. |
|---|---|
| Authors: | Borman S; Castle Biosciences, Inc, Phoenix, AZ, USA., Wilkinson J; Castle Biosciences, Inc, Phoenix, AZ, USA., Meldi-Sholl L; Castle Biosciences, Inc, Phoenix, AZ, USA., Johnson C; Castle Biosciences, Inc, Phoenix, AZ, USA., Carter K; Castle Biosciences, Inc, Phoenix, AZ, USA., Covington KR; Castle Biosciences, Inc, 505 S. Friendswood Dr., Ste 400, Friendswood, TX, 77546, USA., Fitzgerald AL; Castle Biosciences, Inc, 505 S. Friendswood Dr., Ste 400, Friendswood, TX, 77546, USA., Kurley SJ; Castle Biosciences, Inc, 505 S. Friendswood Dr., Ste 400, Friendswood, TX, 77546, USA., Farberg AS; Baylor Scott & White Health System, Dallas, TX, USA., Goldberg MS; Castle Biosciences, Inc, 505 S. Friendswood Dr., Ste 400, Friendswood, TX, 77546, USA.; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Monzon FA; Castle Biosciences, Inc, 505 S. Friendswood Dr., Ste 400, Friendswood, TX, 77546, USA., Oelschlager K; Castle Biosciences, Inc, Phoenix, AZ, USA., Cook RW; Castle Biosciences, Inc, 505 S. Friendswood Dr., Ste 400, Friendswood, TX, 77546, USA. rcook@castlebiosciences.com. |
| Source: | Diagnostic pathology [Diagn Pathol] 2022 Feb 25; Vol. 17 (1), pp. 32. Date of Electronic Publication: 2022 Feb 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-1596 (Electronic) Linking ISSN: 17461596 NLM ISO Abbreviation: Diagn Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1746-1596 |
|---|---|
| DOI: | 10.1186/s13000-022-01211-w |
